1. Amaducci L Maurer K Winblad B Dom R Bullock R Efficacy and safety of nicergoline, 30mg tablets b.i.d. for twelve months, in the treatment of probable Alzheimer's disease. A multicentre, multinational, double-blind, randomized, placebo-controlled, parallel group clinical trial Unpublished report 1999
2. Baldelli MV Pirani A Toschi A Ballotti A Association of nicergoline and psychosensory training treatment in a group of elderly patients with cognitive impairment Congress abstract and unpublished report 1993
3. Nicergoline in Mild to Moderate Dementia: a multicenter, double-blind, placebo-controlled study;Battaglia;Journal of the American Geriatrics Society,1989
4. A 24-month, double-blind, placebo-controlled multicentre pilot study of the efficacy and safety of nicergoline 60 mg per day in elderly hypertensive patients with leukoaraiosis;Bes;European Journal of Neurology,1999
5. Crook TH Lakin DM A double-blind, randomized, placebo-controlled trial of 30mg b.i.d. nicergoline administered for six months to patients with probable Alzheimer's Disease Unpublished report from Pharmacia & Upjohn 1996